Gentex saw the highest growth of 1.49% in patent filings and 1.32% in grants in May in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 0.99% and grants by 0.49%. GlobalData’s DataBook provides a comprehensive analysis of Gentex‘s patent filings and grants. Buy the databook here.
Gentex has been focused on protecting inventions in United States(US) with 24 publications in Q2 2024
The United States(US) Patent Office dominates the patent filings and grants with nearly 93% filings and 100% grants. The United States(US), and European Patent Office(EPO) patent Office are among the top ten patent offices where Gentex is filings its patents. Among the top granted patent authorities, Gentex has 100% of its grants in United States(US).
GENTEX could be the strongest competitor for Gentex
In terms of grant share, Gentex stands in sixth position among its competitors. Gentex and Gentex secured the top positions according to recent patent publication data.
Patents related to health and safety and healthtech lead Gentex's portfolio
Gentex has the highest number of patents in health and safety followed by, healthtech and industrial automation. For health and safety, nearly 33% of patents were filed and no patents were granted in Q2 2024.
Exterior and materials related patents lead Gentex portfolio followed by vision systems, and image management
Gentex has highest number of patents in exterior and materials followed by vision systems, image management, consumer applications, and computer & peripherals. For exterior and materials, nearly 24% of patents were filed and 16% of patents were granted in Q2 2024.
For comprehensive analysis of Gentex's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.